Results 41 to 50 of about 10,710 (166)

An experience in the clinical use of specific immunoglobulin from horse blood serum for prophylaxis of Ebola haemorrhagic fever

open access: yesВопросы вирусологии, 2017
The aim of this work was to estimate the efficacy and safety of single intramuscular introduction of specific heterologous immunoglobulin as prophylactic drug against Ebola hemorrhagic fever. Materials and methods.
I. V. Borisevich   +5 more
doaj   +1 more source

Reemerging Sudan Ebola Virus Disease in Uganda, 2011

open access: yesEmerging Infectious Diseases, 2012
Two large outbreaks of Ebola hemorrhagic fever occurred in Uganda in 2000 and 2007. In May 2011, we identified a single case of Sudan Ebola virus disease in Luwero District.
Trevor Shoemaker   +11 more
doaj   +1 more source

Elevated l-threonine is a biomarker for Lassa fever and Ebola

open access: yesVirology Journal, 2020
Background Lassa fever and Ebola are characterized by non-specific initial presentations that can progress to severe multisystem illnesses with high fatality rates.
Trevor V. Gale   +4 more
doaj   +1 more source

Ebola Virus Hemorrhagic Fever [PDF]

open access: yesMicroscopy and Microanalysis, 2015
This past year has seen the largest Ebola virus outbreak on record, centered in West Africa in Guinea, Liberia, and Sierra Leone. 1 Cases were first reported in Guinea on March 21, 2014; by March 30, cases were reported in Liberia and in May Sierra Leone also reported cases.
openaire   +1 more source

Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time

open access: yesNature Communications, 2020
Outbreaks of viral hemorrhagic fevers highlight the need for sensitive, field-deployable diagnostics. Here the authors present a CRISPR-based SHERLOCK platform with field protocol and mobile app for Ebola and Lassa fever outbreaks.
Kayla G. Barnes   +38 more
doaj   +1 more source

Ebola Hemorrhagic Fever and Septic Shock [PDF]

open access: yesThe Journal of Infectious Diseases, 2003
Ebola virus is the cause of sporadic outbreaks of lethal Ebola hemorrhagic fever (EHF) in central Africa. Despite the difficulties of studying this virus much has been learned over the past decade about the pathogenesis of Ebola virus infection in humans and nonhuman primates.
Mike Bray, Siddhartha Mahanty
openaire   +1 more source

Qualitative Assessment of One Health Operationalization at the Central Level and in Two Border Districts of Sierra Leone

open access: yesPublic Health Challenges, Volume 5, Issue 3, September 2026.
Implementation of the One Health approach in Sierra Leone was stronger at the central level than in districts and communities, where coordination, surveillance, workforce capacity, and funding were limited. Strengthening integrated systems and dedicated financing is essential for effective prevention and control of zoonotic disease threats.
Joseph Anderson Bunting‐Graden   +15 more
wiley   +1 more source

Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone

open access: yesEmerging Infectious Diseases, 2014
Sierra Leone in West Africa is in a Lassa fever–hyperendemic region that also includes Guinea and Liberia. Each year, suspected Lassa fever cases result in submission of ≈500–700 samples to the Kenema Government Hospital Lassa Diagnostic Laboratory in ...
Randal J. Schoepp   +4 more
doaj   +1 more source

Evaluation of the Effectiveness of Nonspecific Medical Protection Against Diseased, Caused of Ebola Virus

open access: yesАнтибиотики и Химиотерапия, 2020
The article presents an analysis of research evaluating the effectiveness of nonspecific means of emergency prevention and treatment of Ebola virus disease.
T. E. Sizikova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy